1 Min Read
May 15 (Reuters) - Syros Pharmaceuticals Inc:
* Syros Pharmaceuticals Inc - resale of up to 2.6 million shares of common stock by the selling stockholders - SEC filing Source text: (bit.ly/2qp4GlQ) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.